|
NEO212 Oral Capsule Clinical Trials
1 actively recruiting trial across 1 location
Also known as: POH-TMZ
Beverly Hills, California1 trial
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Precision NextGen Oncology
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.